Author Question: A system's capacity can be viewed as a(n): A) system benefit. B) on-going issue. C) system ... (Read 87 times)

c0205847

  • Hero Member
  • *****
  • Posts: 531
A system's capacity can be viewed as a(n):
 
  A) system benefit.
  B) on-going issue.
  C) system constraint.
  D) liability.
  E) cost center.

Question 2

A deliverable is an end product in a phase of the SDLC.
 
  Indicate whether the statement is true or false



vish98

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

C
Explanation: C) A constraint is a limit to what a system can do.

Answer to Question 2

TRUE
Explanation: Each phase of the SDLC has a deliverable as the end product, whether it be a project plan or the actual implementation.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

vish98

  • Sr. Member
  • ****
  • Posts: 326

 

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

For a complete list of videos, visit our video library